Our partners

Why collaborate with Hikma?

• Strong market position and established infrastructure necessary for continued growth across the MENA region
• Reputation for high quality products, FDA-approved facilities and a long and successful track record with global licensing partners
• Strong brand recognition and experienced sales and marketing teams throughout MENA with strong customer loyalty
• Local manufacturing facilities and investments in local markets registration and pricing advantages
• Excellent knowledge of registration processes and connections with local health authorities
• Existing network of distribution channels

Currently Hikma collaborates with:

	Æterna Zentaris Inc. Germany		Astellas Japan
	Bio-Tech Pharmacal, Inc. USA		Celltrion Korea
	Dong-A Korea		Dong-Kook Korea
	Edmond Pharma Italy		Elpen Pharmaceutical Company Greece
	Engelhard Arzneimittel Germany		Laboratorios Dr. Esteve S.A. Spain
	FAES Spain		Kaken Japan
	LG Life Sciences Korea		Mitsubishi Tanabe Japan
	Novelty Pharma Switzerland		NTC s.r.l Italy
	Nycomed Austria		Pharmathen Greece
	Piramal healthcare India		ROVI Spain
	SANA Pharmaceutical Research Co. Jordan		Sinclair UK
	Takeda Japan		Teikoku USA
	Vifor Pharma Switzerland